Chlenski et al, demonstrated that enhanced SPARC expression in mouse xenografts through transfected cells, resulted in a decrease in smooth muscle actin expression, as well as impaired xenograft growth, inhibition of angiogenesis and more tumour stroma compared to wild-type and vector-control 293 xenografts[35]. This evidence concerns the gene SPARC and neoplasm.